Balyasny Asset Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$360K Sell
77,700
-176,400
-69% -$920K ﹤0.01% 2494
2025
Q4
$1.27M Buy
254,100
+58,900
+30% +$307K ﹤0.01% 2077
2025
Q3
$990K Buy
195,200
+69,100
+55% +$304K ﹤0.01% 2119
2025
Q2
$543K Buy
+126,100
New +$623K ﹤0.01% 2265
2024
Q1
Sell
-1,500,000
Closed -$7.37M 2928
2023
Q4
$7.37M Sell
1,500,000
-3,500,000
-70% -$17.1M 0.01% 977
2023
Q3
$27.3M Buy
5,000,000
+4,000,000
+400% +$32M 0.06% 462
2023
Q2
$9.26M Buy
1,000,000
+750,000
+300% +$6.34M 0.02% 822
2023
Q1
$2.06M Sell
250,000
-920,000
-79% -$10.2M 0.01% 1450
2022
Q4
$13M Buy
+1,170,000
New +$13.6M 0.04% 627
2020
Q2
Sell
-100,000
Closed -$1.73M 1367
2020
Q1
$1.73M Buy
+100,000
New +$2.09M 0.02% 640

Other funds holding MPT

Balyasny Asset Management's MPT Position: Q1 2026 in Review

Balyasny Asset Management increased its Medical Properties Trust (MPT) stake by 321% in Q1 2026, buying an estimated $2.21M and bringing the position to 556,374 shares worth $2.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1675.

Balyasny Asset Management first reported a position in MPT in Q3 2015 and has held it in 31 quarters since. The position peaked at $84.3M in Q4 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Balyasny Asset Management held 556,374 shares of Medical Properties Trust worth $2.58M as of Q1 2026.
  • Balyasny Asset Management bought 424,312 Medical Properties Trust shares in Q1 2026, an estimated $2.21M.
  • Medical Properties Trust made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1675 holding.
  • Balyasny Asset Management first reported a position in Medical Properties Trust in Q3 2015 and has held it in 31 quarters since.
  • Balyasny Asset Management's Medical Properties Trust position peaked at $84.3M in Q4 2022.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.